Substrate and inhibitor specificities for human monoamine oxidase A and B are influenced by a single amino acid

被引:146
作者
Geha, RM
Rebrin, I
Chen, K
Shih, JC
机构
[1] Univ So Calif, Sch Pharm, Dept Mol Pharmacol & Toxicol, Los Angeles, CA 90089 USA
[2] Univ So Calif, Sch Med, Dept Cell & Neurobiol, Los Angeles, CA 90089 USA
关键词
D O I
10.1074/jbc.M006972200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Monoamine oxidase (MAO) is responsible for the oxidation of biogenic and dietary amines, It exists as two isoforms, A and B, which have a 70% amino acid identity and different substrate and inhibitor specificities. This study reports the identification of residues responsible for conferring this specificity in human MAO A and B, Using site-directed mutagenesis we reciprocally interchanged three pairs of corresponding nonconserved amino acids within the central portion of human MAO. Mutant MAO A-I335Y became like MAO B, which exhibits a higher preference for beta -phenylethylamine than for the MAO A preferred substrate serotonin (5-hydroxytryptamine), and became more sensitive to deprenyl (MAO B-specific inhibitor) than to clorgyline (MAO A-specific inhibitor). The reciprocal mutant MAO B-Y326I exhibited an increased preference for 5-hydroxytryptamine, a decreased preference for beta -phenylethylamine, and, similar to MAO A, was more sensitive to clorgyline than to deprenyl, These mutants also showed a distinct shift in sensitivity for the MAO A- and B-selective inhibitors Ro 41-1049 and Ro 16-6491. Mutant pair MAO A-T245I and MAO B-I236T and mutant pair MAO A-D328G and MAO B-G319D reduced catalytic activity but did not alter specificity. Our results indicate that Ile-335 in MAO A and Tyr-326 in MAO B play a critical role in determining substrate and inhibitor specificities in human MAO A and B.
引用
收藏
页码:9877 / 9882
页数:6
相关论文
共 30 条
  • [1] CDNA CLONING OF HUMAN-LIVER MONOAMINE OXIDASE-A AND OXIDASE-B - MOLECULAR-BASIS OF DIFFERENCES IN ENZYMATIC-PROPERTIES
    BACH, AWJ
    LAN, NC
    JOHNSON, DL
    ABELL, CW
    BEMBENEK, ME
    KWAN, SW
    SEEBURG, PH
    SHIH, JC
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (13) : 4934 - 4938
  • [2] A 30 Å long U-shaped catalytic tunnel in the crystal structure of polyamine oxidase
    Binda, C
    Coda, A
    Angelini, R
    Federico, R
    Ascenzi, P
    Mattevi, A
    [J]. STRUCTURE, 1999, 7 (03) : 265 - 276
  • [3] ABNORMAL-BEHAVIOR ASSOCIATED WITH A POINT MUTATION IN THE STRUCTURAL GENE FOR MONOAMINE OXIDASE-A
    BRUNNER, HG
    NELEN, M
    BREAKEFIELD, XO
    ROPERS, HH
    VANOOST, BA
    [J]. SCIENCE, 1993, 262 (5133) : 578 - 580
  • [4] AGGRESSIVE-BEHAVIOR AND ALTERED AMOUNTS OF BRAIN-SEROTONIN AND NOREPINEPHRINE IN MICE LACKING MAOA
    CASES, O
    SEIF, I
    GRIMSBY, J
    GASPAR, P
    CHEN, K
    POURNIN, S
    MULLER, U
    AGUET, M
    BABINET, C
    SHIH, JC
    DEMAEYER, E
    [J]. SCIENCE, 1995, 268 (5218) : 1763 - 1766
  • [5] CESURA A M, 1988, Pharmacological Research Communications, V20, P51, DOI 10.1016/S0031-6989(88)80547-2
  • [6] Investigation on the structure of the active site of monoamine oxidase-B by affinity labeling with the selective inhibitor lazabemide and by site-directed mutagenesis
    Cesura, AM
    Gottowik, J
    Lahm, HW
    Lang, G
    Imhof, R
    Malherbe, P
    Rothlisberger, U
    DaPrada, M
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1996, 236 (03): : 996 - 1002
  • [7] CESURA AM, 1989, MOL PHARMACOL, V37, P358
  • [8] Chen K, 1996, J NEUROCHEM, V66, P797
  • [9] CHEN K, 1994, MOL PHARMACOL, V46, P1226
  • [10] Crossen R., 1996, BACULOVIRUS EXPRESSI